Created in 2006 (United States), Pearl Therapeutics own 585 sister brands and 17478 competing brands. Pearl Therapeutics is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. Pearl Therapeutics belongs to the Drug Manufacturers business sector.